Ambulatory Esophageal pH Metry vs. Impedance: Which to Choose?

pH Metry Explained: Indications, Procedure, and Interpretation

Introduction

pH metry (esophageal pH monitoring) measures acid exposure in the esophagus to evaluate gastroesophageal reflux disease (GERD) and related symptoms. It helps correlate symptoms with acid reflux events and assess treatment response.

Indications

• Persistent typical GERD symptoms (heartburn, regurgitation) despite empiric therapy
• Atypical/extraesophageal symptoms possibly related to reflux (chronic cough, laryngitis, asthma exacerbation)
• Preoperative evaluation before anti-reflux surgery to confirm pathologic acid exposure
• Assessing response to medical therapy or determining need for therapy escalation
• Refractory or unexplained chest pain after cardiac causes excluded

Types of pH Monitoring

• Catheter-based 24-hour pH monitoring: a thin nasoesophageal catheter with a pH sensor records continuous acid exposure; commonly performed off or on acid-suppressive therapy depending on the clinical question.
• Wireless (Bravo) pH capsule: a small capsule attached endoscopically to the distal esophagus that transmits pH data for 48–96 hours; more comfortable and allows longer monitoring.
• Combined impedance-pH monitoring: measures both refluxate movement (impedance) and pH to detect non-acid and weakly acidic reflux events, useful when symptoms persist on acid suppression.

Pretest Preparation

• Review medications: typically stop proton pump inhibitors (PPIs) 7 days before catheter or per protocol; H2 blockers and prokinetics often stopped 48–72 hours prior. Confirm specifics based on the clinical question.
• Diet and activity: avoid acidic foods and vigorous exercise immediately before and during monitoring unless instructed otherwise.
• Symptom diary: patient should record meal times, body positions (lying down), and symptom occurrences to correlate with recordings.

Procedure: Catheter-Based Monitoring

1. Placement: a thin catheter is inserted through the nose and positioned in the distal esophagus; position confirmed by manometry or by distance from nostril to the lower esophageal sphincter (LES).
2. Recording: device connects to a recorder worn on a belt; patients resume normal activities and keep a diary for 24 hours.
3. Removal: catheter is removed after the monitoring period; data downloaded for analysis.

Procedure: Wireless pH Capsule

1. Endoscopic attachment: capsule is attached to the distal esophageal mucosa during upper endoscopy and transmits data to an external receiver.
2. Monitoring: typically records for 48–96 hours; patients carry a receiver and log symptoms.
3. Capsule detachment: the capsule detaches spontaneously within days and passes per rectum.

Interpretation: Key Metrics

• Percentage time pH <4: the primary measure of acid exposure; normal thresholds vary by system and age but commonly <4% over 24 hours is considered normal for distal esophagus off therapy.
• Number and duration of reflux episodes: counts and longest reflux episode provide context.
• Symptom association measures:
  • Symptom Index (SI): percentage of symptoms associated with reflux episodes; SI ≥50% suggests association.
  • Symptom Association Probability (SAP): statistical measure; SAP ≥95% indicates a significant association.
• DeMeester score (for 24-hour catheter studies): composite score incorporating multiple variables; scores >14.72 typically indicate abnormal acid exposure.

Interpretation: Clinical Scenarios

• Pathologic acid exposure with positive symptom association: supports GERD as the cause of symptoms; consider anti-reflux surgery if refractory to medical therapy and anatomy suitable.
• Pathologic acid exposure with negative symptom association: objective GERD present but symptoms may not be caused by reflux; tailor treatment accordingly.
• Normal acid exposure with positive symptom association: suggests symptom sensitivity to physiological reflux; consider neuromodulators or behavioral therapies.
• Normal acid exposure and negative association: reflux unlikely the cause; investigate other etiologies.

Limitations and Pitfalls

• Day-to-day variability: reflux can vary; longer monitoring (wireless) improves diagnostic yield.
• Effects of stopping acid suppression: withholding PPIs can provoke rebound acid hypersecretion and affect results; follow protocol.
• Incorrect sensor placement or technical failure: ensure proper positioning and device checks.
• Non-acid reflux not detected by pH-only monitoring: consider impedance-pH when non-acid reflux is suspected.

Complications and Safety

• Catheter discomfort, nasal irritation, sore throat.
• Rare: esophageal mucosal injury, capsule retention (very uncommon).
• Wireless capsule generally better